Phathom Pharmaceuticals guided FY 2026 revenue as high as $345 million while building out a sales force of more than 290 representatives. The revised outlook now tops out at $325 million, and PHAT shareholders absorbed the decline. NEW YORK, July 30, 2026 /PRNewswire/ -- Phathom...
Hence then, the article about phathom pharmaceuticals investigation notice levi korsinsky notifies investors of pending investigation into phathom pharmaceuticals phat was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Phathom Pharmaceuticals Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Phathom Pharmaceuticals (PHAT) )
Also on site :
- Netflix sued for $105M by billionaire movie producer after his unreleased Nicolas Cage thriller goes missing
- We Asked 4 Psychologists What Usually Causes Adult Siblings To Drift Apart—They All Said the Same Thing
- ‘The Walking Dead’ Franchise to Stream on Both Netflix and AMC+ Beginning in 2027 Under New $500 Million Deal